Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan and Rosuvastatin Co-administration in Hypertension with Hyperlipidemia
NCT02087540Phase 3Unknown
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- May 2013
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by Ildong Pharmaceutical Co Ltd. Status: unknown.
02
Drugs
telmisartanrosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02087540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087540.